Nonsteroidal anti-inflammatory drugs for treatment of advanced gastric cancer: cyclooxygenase-2 is involved in hepatocyte growth factor mediated tumor developmentand progression

This publication has 26 references indexed in Scilit:

• Significant Correlation between Serum Level of Hepatocyte Growth Factor and Progression of Gastric Carcinoma
  World Journal of Surgery, 1999
• Correlation of hepatocyte growth factor-induced proliferation and calcium-activated potassium current in human gastric cancer cells
  Biochimica et Biophysica Acta (BBA) - Biomembranes, 1998
• Roles of hepatocyte growth factor and its receptor Met during gastric ulcer healing in rats
  Gastroenterology, 1997
• Increase in the circulating level of hepatocyte growth factor in gastric cancer patients
  British Journal of Cancer, 1997
• Relation of number of positive lymph nodes to the prognosis of patients with primary gastric adenocarcinoma.
  Gut, 1996
• Aberrant expression of c‐met mRNA in human gastric carcinomas
  International Journal of Cancer, 1993
• Scatter factor induces blood vessel formation in vivo.
  Proceedings of the National Academy of Sciences, 1993
• Regulation of cell growth and motility by hepatocyte growth factor and receptor expression in various cell species
  Experimental Cell Research, 1992
• Scatter Factor Regulates Vascular Endothelial Cell Motility
  Cancer Investigation, 1990
• Purification and partial characterization of hepatocyte growth factor from plasma of a patient with fulminant hepatic failure.
  Journal of Clinical Investigation, 1988